Justin Bader, MBA, PharmD

Director, Clinical Pharmacology
Bicycle Therapeutics

Poster(s):

• CT-012 - PHARMACOKINETICS OF BT8009, A BICYCLE TOXIN CONJUGATE (BTC), IN PATIENTS WITH SOLID TUMOR MALIGNANCIES AND VARIOUS DEGREES OF RENAL FUNCTIONS
  Tuesday, March 26, 2024

  4:35 PM – 5:30 PM MDT

• PII-062 - PHARMACOKINETICS OF BT8009, A BICYCLE TOXIN CONJUGATE (BTC), IN PATIENTS WITH SOLID TUMOR MALIGNANCIES AND VARIOUS DEGREES OF RENAL FUNCTIONS
  Thursday, March 28, 2024

  5:00 PM – 6:30 PM MDT